What is the highest ICD‑10‑CM code for Type 1 diabetes mellitus with uncontrolled blood glucose that will qualify for Medicaid coverage of the Dexcom G7 continuous glucose‑monitoring sensor and receiver?

ICD-10-CM Coding for T1DM with Uncontrolled Blood Glucose for Medicaid CGM Coverage

For Type 1 diabetes with uncontrolled blood glucose requiring Dexcom G7 CGM coverage through Medicaid, use E10.65 (Type 1 diabetes mellitus with hyperglycemia) as your primary diagnosis code, ensuring it appears in the primary position on claims.

Understanding the Clinical and Coverage Context

The American Diabetes Association guidelines establish that CGM should be considered in all children and adolescents with type 1 diabetes, and real-time CGM in conjunction with insulin therapy is a useful tool to lower A1C levels and/or reduce hypoglycemia in adults with type 1 diabetes who are not meeting glycemic targets 1. The Dexcom G7 is an FDA-approved real-time CGM system that meets these clinical indications 2.

Specific ICD-10-CM Code Selection

For uncontrolled Type 1 diabetes with elevated blood glucose, the most appropriate codes are:

• E10.65 - Type 1 diabetes mellitus with hyperglycemia (PRIMARY CODE)
• E10.641 - Type 1 diabetes mellitus with hypoglycemia with coma (if applicable)
• E10.649 - Type 1 diabetes mellitus with hypoglycemia without coma (if applicable)

Critical Coding Considerations

Diagnosis position matters significantly for claims accuracy. Research demonstrates that hypoglycemia codes in the primary position have a positive predictive value of 95.6% versus only 46.5% when in secondary positions 3. This principle applies to all diabetes diagnosis coding for coverage determinations.

The "uncontrolled" descriptor in clinical documentation should translate to either:

• Hyperglycemia (E10.65) - most common for uncontrolled diabetes
• Hypoglycemia (E10.641 or E10.649) - if recurrent low blood sugars are the primary issue
• Both may be coded if both conditions are present and documented

Documentation Requirements to Support Coverage

To maximize Medicaid approval for G7 sensors and receiver, your clinical documentation must demonstrate:

1. Confirmed Type 1 diabetes diagnosis - The ICD-10 codes for T1DM (E10.x series) have been validated with 96.3% specificity and 96.8% negative predictive value for distinguishing T1DM from T2DM 4

2. Intensive insulin therapy - Document multiple daily injections (≥3 per day) or continuous subcutaneous insulin infusion (pump therapy) 5, 1

3. Failure to meet glycemic targets - Document elevated A1C levels or frequent glucose excursions 1

4. One or more of the following:

   • Hypoglycemia unawareness
   • Recurrent hypoglycemic episodes
   • Unexplained hyperglycemia (especially fasting)
   • Dramatic glycemic variability
   • Nocturnal hypoglycemia 5, 1

Common Pitfalls to Avoid

Do not use E11.x codes (Type 2 diabetes) for Type 1 diabetes patients - even if the patient has some insulin resistance. The code series matters for coverage determinations, and mixing T1DM and T2DM codes creates confusion that can lead to denials.

Avoid vague "uncontrolled" terminology without specificity - Always specify whether uncontrolled means hyperglycemia, hypoglycemia, or both. The code E10.9 (Type 1 diabetes without complications) is insufficient for CGM coverage justification.

Do not rely on adverse event/poisoning codes - Research shows these codes would miss 97% of true hypoglycemic events and do not improve accuracy for coverage determinations 3.

Supporting Clinical Rationale

The evidence strongly supports CGM use in T1DM. Guidelines indicate that real-time CGM devices should be used as close to daily as possible for maximal benefit 1. The Dexcom G7 specifically has demonstrated accuracy with overall MARD of 8.0% and 87.7% of readings within ±15 mg/dL or ±15% of reference values in adults with diabetes 6.

CGM is now considered standard of care for most people with type 1 diabetes 7, with consistent evidence showing A1C reductions of 0.4-1.5%, substantial reductions in hypoglycemic events (up to 72-79% reduction), and improved time in range 8.

Practical Claim Submission Strategy

1. List E10.65 (or appropriate E10.64x code) in the PRIMARY diagnosis position
2. Include supporting diagnoses that document complications or management challenges
3. Ensure clinical notes explicitly document intensive insulin therapy regimen
4. Document specific glycemic control issues (A1C values, frequency of hypo/hyperglycemia)
5. Note that patient requires SMBG capability for calibration/verification as required by guidelines 1

The algorithm for code selection is straightforward: If blood glucose is predominantly elevated = E10.65; if recurrent lows without coma = E10.649; if recurrent lows with coma = E10.641; if both highs and lows are problematic = code both E10.65 and E10.649.